Potential toxicity of sulfanilamide antibiotic: Binding of sulfamethazine to human serum albumin

Science of the Total Environment

Volumn 432, Issue , 2012, Pages 269-274

  Chen, Jiabin ^a   Zhou, Xuefei ^b   Zhang, Yalei ^a   Gao, Haiping ^b  

^a TONGJI UNIVERSITY   (China)

^b NONE   (China)

Author keywords

Capillary electrophoresis; HSA; Non covalent interaction; Sulfamethazine; Thermodynamics

Indexed keywords

BINDING CONSTANT; BINDING DISTANCE; BINDING FORCES; DAILY LIVES; ENTHALPY CHANGE; EQUILIBRIUM DIALYSIS; FLUORESCENCE SPECTROMETRY; HSA; HUMAN HEALTH; HUMAN SERUM ALBUMINS; NON-COVALENT INTERACTION; POTENTIAL THREATS; PROTEIN DAMAGE; QUANTITATIVE EVALUATION METHODS; SECONDARY CONFORMATION; SUBDOMAIN; SULFAMETHAZINE; TRYPTOPHAN RESIDUES; VITAMIN B;

AMINO ACIDS; CAPILLARY ELECTROPHORESIS; DIALYSIS; ENERGY TRANSFER; FLUORESCENCE SPECTROSCOPY; HEALTH RISKS; HYDROGEN BONDS; THERMODYNAMICS;

ANTIBIOTICS;

HUMAN SERUM ALBUMIN; POLYPEPTIDE; RIBOFLAVIN; SULFADIMIDINE; SULFANILAMIDE; TRYPTOPHAN;

ANTIBIOTICS; CHEMICAL BONDING; ELECTROKINESIS; FLUORESCENCE SPECTROSCOPY; HEALTH IMPACT; PEPTIDE; SERUM; SULFUR COMPOUND; THERMODYNAMICS; TOXICITY;

ARTICLE; BINDING AFFINITY; CAPILLARY ELECTROPHORESIS; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; DRUG BINDING SITE; DRUG PROTEIN BINDING; ENERGY TRANSFER; ENTHALPY; EQUILIBRIUM DIALYSIS; HYDROGEN BOND; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEFECT; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN SECONDARY STRUCTURE; PROTEIN UNFOLDING; QUANTITATIVE ANALYSIS; SPECTROFLUOROMETRY; STATIC ELECTRICITY; TOXICITY TESTING;

ANTI-INFECTIVE AGENTS; CIRCULAR DICHROISM; ELECTROPHORESIS, CAPILLARY; ENVIRONMENTAL POLLUTANTS; FLUOROPHOTOMETRY; HUMANS; PROTEIN BINDING; SERUM ALBUMIN; SPECTROPHOTOMETRY; SULFAMETHAZINE; THERMODYNAMICS;

EID: 84862731494     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2012.06.003     Document Type: Article

References (44)

1. Bi S., Yan L., Sun Y., Zhang H. Investigation of ketoprofen binding to human serum albumin by spectral methods. Spectrochim Acta A 2011, 78:410-414.
2. Carter D.C., Chang B., Ho J.X., Keeling K., Krishnasami Z. Preliminary crystallographic studies of four crystal forms of serum albumin. Eur J Biochem 1994, 226:1049-1052.
3. Chen F.F., Tang Y.N., Wang S.L., Gao H.W. Binding of brilliant red compound to lysozyme: insights into the enzyme toxicity of water-soluble aromatic chemicals. Amino Acids 2009, 36:399-407.
4. Christian T., Schneider R.J., Färber H.A., Skutlarek D., Meyer M.T., Goldbach H.E. Determination of antibiotic residues in manure, soil, and surface waters. Acta Hydroch Hydrob 2003, 31:36-44.
5. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspect 1999, 107:907-938.
6. Ding F., Zhao G., Chen S., Liu F., Sun Y., Zhang L. Chloramphenicol binding to human serum albumin: determination of binding constants and binding sites by steady-state fluorescence. J Mol Struct 2009, 929:159-166.
7. Eftink M.R., Ghiron C.A. Fluorescence quenching studies with proteins. Anal Biochem 1981, 114:199-227.
8. Förster T. Zwischenmolekulare Energiewanderung und Fluoreszenz. Ann Phys 1948, 437:55-75.
9. Gao H.W., Xu Q., Chen L., Wang S.L., Wang Y., Wu L.L., et al. Potential protein toxicity of synthetic pigments: binding of poncean S to human serum albumin. Biophys J 2008, 94:906-917.
10. Ge F., Jiang L., Liu D., Chen C. Interaction between alizarin and human serum albumin by fluorescence spectroscopy. Anal Sci 2011, 27:79-84.
11. Ghuman J., Zunszain P.A., Petitpas I., Bhattacharya A.A., Otagiri M., Curry S. Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol 2005, 353:38-52.
12. Glazer A.N., Smith E.L. Studies on the ultraviolet difference spectra of proteins and polypeptides. J Biol Chem 1961, 236:2942-2947.
13. Halling-Sorensen B., Nielsen S.N., Lanzky P.F., Ingerslev F., Lutzhoft H.C.H., Jorgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 1998, 36:357-394.
14. Hirsch R., Ternes T., Haberer K., Kratz K.L. Occurrence of antibiotics in the aquatic environment. Sci Total Environ 1999, 225:109-118.
15. Hu Y.J., Liu Y., Zhang L.X., Zhao R.M., Qu S.S. Studies of interaction between colchicine and bovine serum albumin by fluorescence quenching method. J Mol Struct 2005, 750:174-178.
16. Jorgensen S.E., Halling-Sorensen B. Drugs in the environment. Chemosphere 2000, 40:691-699.
17. Kalanur S.S., Seetharamappa J., Kalalbandi V.K.A. Characterization of interaction and the effect of carbamazepine on the structure of human serum albumin. J Pharm Biomed Anal 2010, 53:660-666.
18. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ Sci Technol 2002, 36:1202-1211.
19. Lin A.Y.C., Tsai Y.T. Occurrence of pharmaceuticals in Taiwan's surface waters: impact of waste streams from hospitals and pharmaceutical production facilities. Sci Total Environ 2009, 407:3793-3802.
20. Lin C.E., Chang C.C., Lin W.C. Migration behavior and separation of sulfonamides in capillary zone electrophoresis III. Citrate buffer as a background electrolyte. J Chromatogr A 1997, 768:105-112.
21. Mahammed A., Gray H.B., Weaver J.J., Sorasaenee K., Gross Z. Amphiphilic corroles bind tightly to human serum albumin. Bioconjug Chem 2004, 15:738-746.
22. Martinez-Gomez M.A., Carril-Aviles M.M., Sagrado S., Villanueva-Camanas R.M., Medina-Hernandez M.J. Characterization of antihistamine-human serum protein interactions by capillary electrophoresis. J Chromatogr A 2007, 1147:261-269.
23. Moellering R.C. NDM-1-a cause for worldwide concern. N Engl J Med 2010, 363:2377-2379.
24. Østergaard J., Heegaard N.H.H. Capillary electrophoresis frontal analysis: principles and applications for the study of drug-plasma protein binding. Electrophoresis 2003, 24:2903-2913.
25. Pailler J.Y., Krein A., Pfister L., Hoffmann L., Guignard C. Solid phase extraction coupled to liquid chromatography-tandem mass spectrometry analysis of sulfonamides, tetracyclines, analgesics and hormones in surface water and wastewater in Luxembourg. Sci Total Environ 2009, 407:4736-4743.
26. Poirier L.A., Doerge D.R., Gaylor D.W., Miller M.A., Lorentzen R.J., Casciano D.A., et al. An FDA review of sulfamethazine toxicity. Regul Toxicol Pharmacol 1999, 30:217-222.
27. Punith R., Katrahalli U., Kalanur S.S., Jaldappagari S. Mechanistic and conformational studies on the interaction of anti-inflammatory drugs, isoxicam and tenoxicam with bovine serum albumin. J Lumin 2010, 130:2052-2058.
28. Sklar L.A., Hudson B.S., Simoni R.D. Conjugated polyene fatty acids as fluorescent probes: synthetic phospholipid membrane studies. Biochemistry 1977, 16:819-828.
29. Song C., Gao N.Y., Gao H.W. Transmembrane distribution of kanamycin and chloramphenicol: insights into the cytotoxicity of antibacterial drugs. Mol Biosyst 2010, 6:1901-1910.
30. Song C., Gao H.W., Wu L.L. Transmembrane transport of microcystin to danio rerio zygotes: insights into the developmental toxicity of environmental contaminants. Toxicol Sci 2011, 122:395-405.
31. Stryer L. The interaction of a naphthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of non-polar binding sites. J Mol Biol 1965, 13:482-495.
32. Sudlow G., Birkett D.J., Wade D.N. Further characterization of specific drug binding sites on human serum albumin. Mol Pharm 1976, 12:1052-1061.
33. Sulkowska A., Bojko B., Rownicka J., Rezner P., Sulkowski W.W. The competition of drugs to serum albumin in combination chemotherapy: NMR study. J Mol Struct 2005, 744:781-787.
34. Tanaka Y., Terabe S. Estimation of binding constants by capillary electrophoresis. J Chromatogr B 2002, 768:81-92.
35. Tang J.H., Luan F., Chen X.G. Binding analysis of glycyrrhetinic acid to human serum albumin: fluorescence spectroscopy, FTIR, and molecular modeling. Bioorg Med Chem 2006, 14:3210-3217.
36. Wang Z.H., Zhang S.X., Shen J.Z., Sergei A.E. Analysis of sulfamethazine by fluorescence polarization immunoassay. Chin J Anal Chem 2007, 35:819-824.
37. Weiss S. Fluorescence spectroscopy of single biomolecules. Science 1999, 283:1676-1683.
38. Wu L.L., Gao H.W., Gao N.Y., Chen F.F., Chen L. Interaction of perfluorooctanoic acid with human serum albumin. BMC Struct Biol 2009, 9:1-7.
39. Wu L.L., Chen L., Song C., Liu X.W., Deng H.P., Gao N.Y., et al. Potential enzyme toxicity of perfluorooctanoic acid. Amino Acids 2010, 38:113-120.
40. Yang L. Molecular recognition of DNA targeting small molecule drugs. J Beijing Med Univ 1998, 30:97-99.
41. Ye S., Yao Z., Na G., Wang J., Ma D. Rapid simultaneous determination of 14 sulfonamides in wastewater by liquid chromatography tandem mass spectrometry. J Sep Sci 2007, 30:2360-2369.
42. Zhang X., Chen L., Fei X.C., Ma Y.S., Gao H.W. Binding of PFOS to serum albumin and DNA: insight into the molecular toxicity of perfluorochemicals. BMC Mol Biol 2009, 10:1-12.
43. Zhang Y.Z., Zhou B., Zhang X.P., Huang P., Li C.H., Liu Y. Interaction of malachite green with bovine serum albumin: Determination of the binding mechanism and binding site by spectroscopic methods. J Hazard Mater 2009, 163:1345-1352.
44. Zhang Y.L., Zhang X., Fei X.C., Wang S.L., Gao H.W. Binding of bisphenol A and acrylamide to BSA and DNA: insights into the comparative interactions of harmful chemicals with functional biomacromolecules. J Hazard Mater 2010, 182:877-885.